A Decade of Progress in Deep Brain Stimulation of the Subcallosal Cingulate for the Treatment of Depression
Open Access
- 12 October 2020
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (10), 3260
- https://doi.org/10.3390/jcm9103260
Abstract
Major depression contributes significantly to the global disability burden. Since the first clinical study of deep brain stimulation (DBS), over 446 patients with depression have now undergone this neuromodulation therapy, and 29 animal studies have investigated the efficacy of subgenual cingulate DBS for depression. In this review, we aim to provide a comprehensive overview of the progress of DBS of the subcallosal cingulate in humans and the medial prefrontal cortex, its rodent homolog. For preclinical animal studies, we discuss the various antidepressant-like behaviors induced by medial prefrontal cortex DBS and examine the possible mechanisms including neuroplasticity-dependent/independent cellular and molecular changes. Interestingly, the response rate of subcallosal cingulate Deep brain stimulation marks a milestone in the treatment of depression. DBS achieved response and remission rates of 64–76% and 37–63%, respectively, from clinical studies monitoring patients from 6–24 months. Although some studies showed its stimulation efficacy was limited, it still holds great promise as a therapy for patients with treatment-resistant depression. Overall, further research is still needed, including more credible clinical research, preclinical mechanistic studies, precise selection of patients, and customized electrical stimulation paradigms.Funding Information
- Research Grants Council, University Grants Committee (RGC-ECS 27104616)
This publication has 150 references indexed in Scilit:
- Violence, mental illness, and the brain - A brief history of psychosurgery: Part 2 - From the limbic system and cingulotomy to deep brain stimulationSurgical Neurology International, 2013
- The Plasticity of Extinction: Contribution of the Prefrontal Cortex in Treating Addiction through Inhibitory LearningFrontiers in Psychiatry, 2013
- Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescentsPublished by Wiley ,2012
- Frontal Theta Cordance Predicts 6-Month Antidepressant Response to Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression: A Pilot StudyNeuropsychopharmacology, 2012
- Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agentsTrends in Neurosciences, 2012
- Neurostimulatory and ablative treatment options in major depressive disorder: a systematic reviewActa Neurochirurgica, 2010
- Depletion of central BDNF in mice impedes terminal differentiation of new granule neurons in the adult hippocampusMolecular and Cellular Neuroscience, 2008
- A developmental twin study of symptoms of anxiety and depression: evidence for genetic innovation and attenuationPsychological Medicine, 2008
- A meta‐analytic study of changes in brain activation in depressionHuman Brain Mapping, 2007
- Neurotrophin-regulated signalling pathwaysPhilosophical Transactions B, 2006